Willem Daniel Francois Venter Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT02670772
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now